Monoclonal Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Monoclonal Antibody Therapy Market Growth and it is Segmented by Production Methods (In Vivo and In Vitro), Source (Chimeric, Human, Humanized, and Murine), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Other Indications), End Users (Hospitals, Research Institutes, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD million) for the Above Segments.

Monoclonal Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Monoclonal Antibodies Industry Overview

The monoclonal antibodies market is expected to be highly competitive with the number of established companies in the market and the new incoming companies, which are investing heavily in R&D with new and advanced technologies. In the current scenario, COVID-19 and cancer therapeutics are expected to be the major domain of competition between the companies. Some of the major key players of the global monoclonal antibodies market are - Eli Lilly, F Hoffmann-La Roche, Merck, Amgen Inc., and Novartis AG, among others.

Monoclonal Antibodies Market Leaders

  1. Merck Group

  2. Eli Lilly and Company

  3. Amgen Inc.

  4. Novartis AG

  5. F Hoffmann-La Roche AG

  6. *Disclaimer: Major Players sorted in no particular order
Monoclonal Antibodies Market Concentration

Monoclonal Antibody Therapy Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?